B Braun has announced the enrolment of the first patient in the BASKET BALL trial, an international, randomised, multicentre, open-label trial in patients with coronary artery disease and increased clinical or anatomical risk. The trial is designed to create clinical evidence for a sirolimus-coated balloon—SeQuent SCB—in complex coronary artery disease. The hypothesis of BASKET BALL […] The post BASKET BALL trial of sirolimus-coated balloon in complex coronary disease gets underway appeared first on Cardiovascular News .